TXG [NASD]
10x Genomics, Inc.
Index- P/E- EPS (ttm)-1.48 Insider Own1.90% Shs Outstand114.11M Perf Week-0.88%
Market Cap3.86B Forward P/E- EPS next Y-1.22 Insider Trans-0.55% Shs Float90.75M Perf Month27.79%
Income-167.20M PEG- EPS next Q-0.32 Inst Own90.40% Short Float / Ratio9.42% / 6.84 Perf Quarter6.32%
Sales503.70M P/S7.67 EPS this Y90.20% Inst Trans-1.05% Short Interest8.55M Perf Half Y-31.65%
Book/sh6.80 P/B5.15 EPS next Y25.20% ROA-16.60% Target Price49.78 Perf Year-75.78%
Cash/sh4.10 P/C8.54 EPS next 5Y- ROE-21.00% 52W Range23.81 - 157.74 Perf YTD-76.51%
Dividend- P/FCF- EPS past 5Y- ROI-6.90% 52W High-77.82% Beta-
Dividend %- Quick Ratio4.30 Sales past 5Y- Gross Margin77.90% 52W Low46.96% ATR2.39
Employees1239 Current Ratio5.00 Sales Q/Q4.60% Oper. Margin-31.90% RSI (14)53.18 Volatility4.74% 7.41%
OptionableYes Debt/Eq0.00 EPS Q/Q-137.20% Profit Margin-33.20% Rel Volume0.63 Prev Close34.72
ShortableYes LT Debt/Eq0.00 EarningsNov 02 AMC Payout- Avg Volume1.25M Price34.99
Recom2.30 SMA201.65% SMA5013.74% SMA200-25.60% Volume787,432 Change0.78%
Aug-18-22Downgrade Goldman Neutral → Sell $55 → $35
Jul-25-22Initiated Canaccord Genuity Buy $55
Jul-15-22Downgrade William Blair Outperform → Mkt Perform
Jul-15-22Downgrade BofA Securities Neutral → Underperform $35
Oct-15-21Resumed Cowen Outperform $205
Sep-14-21Downgrade BofA Securities Buy → Neutral $180
Mar-15-21Initiated William Blair Outperform
Dec-02-20Initiated Goldman Neutral $150
Sep-09-20Initiated Morgan Stanley Overweight $135
Jul-10-20Initiated Stifel Buy $105
Show Previous Ratings
Nov-09-22 04:05PM
06:14AM
Nov-04-22 07:24PM
11:37AM
Nov-02-22 05:45PM
04:05PM Loading…
04:05PM
Nov-01-22 02:37PM
Oct-31-22 04:05PM
Oct-24-22 11:04AM
Oct-12-22 04:05PM
Oct-07-22 10:00AM
Oct-03-22 08:20PM
Sep-23-22 06:04AM
Sep-15-22 09:39AM
Sep-12-22 07:48AM
04:05PM Loading…
Sep-02-22 04:05PM
Aug-18-22 09:14AM
Aug-13-22 08:29AM
Aug-08-22 06:45PM
05:49PM
04:05PM
Aug-02-22 10:00AM
Aug-01-22 10:00AM
Jul-29-22 03:08PM
Jul-28-22 04:05PM
03:40PM
Jul-19-22 01:51PM
Jul-15-22 04:21PM
04:08PM
11:09AM
05:00PM Loading…
Jul-14-22 05:00PM
04:31PM
04:06PM
04:05PM
Jul-13-22 09:10AM
Jun-30-22 09:29AM
Jun-23-22 07:00AM
Jun-16-22 07:24AM
Jun-07-22 07:00AM
Jun-04-22 09:00AM
Jun-03-22 11:43AM
May-13-22 04:00PM
May-05-22 08:32AM
May-04-22 06:35PM
04:05PM
Apr-27-22 03:03PM
Apr-26-22 04:05PM
Apr-20-22 08:25AM
Apr-14-22 08:55AM
Apr-08-22 10:15AM
Apr-07-22 04:05PM
06:35AM
Apr-05-22 09:33AM
Mar-31-22 06:00PM
Mar-25-22 12:39PM
Mar-21-22 06:00AM
05:55AM
Mar-18-22 10:08AM
Mar-01-22 04:05PM
Feb-28-22 06:00AM
Feb-22-22 04:15PM
Feb-20-22 08:50AM
Feb-17-22 11:37AM
09:16AM
05:53AM
Feb-16-22 05:55PM
04:05PM
Feb-14-22 04:09PM
Feb-09-22 03:01PM
Feb-08-22 01:38PM
Jan-28-22 08:00AM
Jan-27-22 06:23PM
Jan-26-22 04:05PM
09:38AM
Jan-21-22 09:00AM
Jan-07-22 09:12AM
Dec-22-21 04:05PM
08:54AM
Dec-20-21 05:38AM
Dec-18-21 03:38AM
Dec-17-21 05:15PM
04:38PM
09:04AM
Dec-15-21 12:38AM
Dec-11-21 05:38AM
Dec-09-21 08:15PM
Dec-01-21 05:06PM
Nov-28-21 04:02AM
Nov-24-21 11:30AM
Nov-19-21 11:45AM
Nov-18-21 09:10AM
Nov-11-21 05:29PM
07:15AM
Nov-03-21 11:00PM
06:25PM
04:05PM
Oct-27-21 03:03PM
Oct-25-21 06:00AM
Oct-18-21 09:57AM
Oct-13-21 10:30AM
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saxonov SergeChief Executive OfficerNov 22Sale34.072,67691,158974,926Nov 23 05:02 PM
McAnear Justin J.Chief Financial OfficerNov 22Sale34.071,62655,39276,764Nov 23 05:02 PM
Hindson Benjamin J.See RemarksNov 22Sale34.072,36180,434217,713Nov 23 05:02 PM
Kosaraju SridharDirectorSep 14Option Exercise11.4810,000114,80030,578Sep 16 05:30 PM
Saxonov SergeChief Executive OfficerSep 12Option Exercise1.2011,50013,800977,602Sep 14 05:55 PM
McAnear Justin J.Chief Financial OfficerAug 23Sale35.1998734,73458,092Aug 25 04:59 PM
Saxonov SergeChief Executive OfficerAug 23Sale35.192,71595,544966,102Aug 25 05:00 PM
Hindson Benjamin J.See RemarksAug 23Sale35.191,29245,467186,246Aug 25 04:58 PM
Saxonov SergeChief Executive OfficerMay 23Sale48.762,656129,516968,817May 25 06:33 PM
McAnear Justin J.Chief Financial OfficerMay 23Sale48.7696747,15559,079May 25 06:32 PM
Hindson Benjamin J.See RemarksMay 23Sale48.761,26461,637187,538May 25 06:30 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerMay 23Sale48.7628613,94797,237May 25 06:28 PM
Kosaraju SridharDirectorMay 16Option Exercise11.4815,000172,20018,458May 17 05:30 PM
McAnear Justin J.Chief Financial OfficerMay 13Buy40.491586,39760,046May 17 05:28 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerMay 13Buy40.491586,39797,523May 17 05:25 PM
Saxonov SergeChief Executive OfficerFeb 22Sale78.6055143,309912,742Feb 24 07:39 PM
Hindson Benjamin J.See RemarksFeb 22Sale78.5936028,294160,326Feb 24 07:40 PM
McAnear Justin J.Chief Financial OfficerFeb 22Sale78.6028822,63738,531Feb 24 07:38 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerFeb 22Sale78.6028822,63797,365Feb 24 07:37 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerFeb 15Option Exercise1.1617,00019,720114,653Feb 17 04:48 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerFeb 15Sale95.1317,0001,617,26197,653Feb 17 04:48 PM
Saxonov SergeChief Executive OfficerFeb 08Option Exercise11.483,03834,876925,293Feb 10 05:46 PM
Saxonov SergeChief Executive OfficerFeb 08Sale89.9012,0001,078,786913,293Feb 10 05:46 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerJan 12Option Exercise1.1617,00019,720114,653Jan 14 04:32 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerJan 12Sale119.0017,0002,023,01997,653Jan 14 04:32 PM
Saxonov SergeChief Executive OfficerJan 04Option Exercise11.483,03734,865937,255Jan 06 06:55 PM
Saxonov SergeChief Executive OfficerJan 04Sale141.3315,0002,120,023922,255Jan 06 06:55 PM
Hindson Benjamin J.See RemarksJan 03Option Exercise71.4241,6662,975,950202,352Jan 05 05:15 PM
McAnear Justin J.Chief Financial OfficerJan 03Option Exercise5.0410,00050,40048,819Jan 05 05:16 PM
Hindson Benjamin J.See RemarksJan 03Sale146.0841,6666,086,404160,686Jan 05 05:15 PM
McAnear Justin J.Chief Financial OfficerJan 03Sale146.0710,0001,460,65138,819Jan 05 05:16 PM
STUELPNAGEL JOHN RDirectorDec 30Sale150.925,000754,590341,616Jan 04 06:13 PM
Kosaraju SridharDirectorDec 30Sale150.381,500225,5693,000Jan 04 06:16 PM
Saxonov SergeChief Executive OfficerDec 28Option Exercise1.2056,36367,636934,218Dec 30 07:32 PM
Hindson Benjamin J.See RemarksDec 28Option Exercise1.14113,920129,690160,686Dec 30 07:31 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerDec 21Option Exercise4.7154,598257,17297,653Dec 23 04:26 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerDec 13Option Exercise1.1617,00019,72060,055Dec 15 07:07 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerDec 13Sale139.3617,0002,369,09643,055Dec 15 07:07 PM
Saxonov SergeChief Executive OfficerDec 07Option Exercise7.418,24661,118892,855Dec 09 05:47 PM
Saxonov SergeChief Executive OfficerDec 07Sale145.9715,0002,189,524877,855Dec 09 05:47 PM
Hindson Benjamin J.See RemarksDec 01Option Exercise15.1441,666630,76888,432Dec 03 05:53 PM
McAnear Justin J.Chief Financial OfficerDec 01Option Exercise5.0410,00050,40048,819Dec 03 05:55 PM
McAnear Justin J.Chief Financial OfficerDec 01Sale147.7510,0001,477,48138,819Dec 03 05:55 PM
Hindson Benjamin J.See RemarksDec 01Sale148.0841,6666,169,69746,766Dec 03 05:53 PM
STUELPNAGEL JOHN RDirectorDec 01Sale151.165,000755,820346,616Dec 03 05:51 PM